Trifloxystrobin

Hazard statements (CLP)

H317, H362, H410

Code

Statements

H317

May cause an allergic skin reaction

SECTION 2: Hazards identification

2.1 Classification of the substance or mixture

Skin sensitisation, (Category 1) H317: May cause an allergic skin reaction. Effects on or via lactation H362: May cause harm to breast-fed children. Short-term (acute) aquatic H400: Very toxic to aquatic life. hazard, (Category 1) Long-term (chronic) aquatic H410: Very toxic to aquatic life with long hazard, (Category 1) lasting effects.

Signal word

Warning Warning

Hazard statements

H317 May cause an allergic skin reaction. H362 May cause harm to breast-fed children. H410 Very toxic to aquatic life with long lasting effects. H317 May cause an allergic skin reaction. H362 May cause harm to breast-fed children.

Precautionary statements

P260 Do not breathe dust. P263 Avoid contact during pregnancy and while nursing. P273 Avoid release to the environment. P280 Wear protective gloves. P302 + P352 IF ON SKIN: Wash with plenty of water. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P280 Wear protective gloves. P302 + P352 IF ON SKIN: Wash with plenty of water.

Supplemental label elements

none Reduced Labelling (<= 125 ml) none

Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher

ECOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

TOXICOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.